Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1479 Inhibitors

Olr1479 inhibitors represent a distinct class of chemical compounds that are specifically designed to interact with and inhibit the Olr1479 receptor, a member of the olfactory receptor family within the G-protein coupled receptor (GPCR) superfamily. Olfactory receptors, including Olr1479, are primarily responsible for detecting and transducing odorant molecules into neural signals that contribute to the sense of smell. The Olr1479 receptor, like other GPCRs, operates by binding to specific ligands, which then trigger a sequence of intracellular signaling events that ultimately lead to the perception of different odors. Inhibitors of Olr1479 are designed to disrupt this process by binding to the receptor, thereby blocking the natural ligands from activating the receptor. This inhibition can occur through direct competition at the receptor's active site or by binding to allosteric sites, which may induce conformational changes that prevent the receptor from functioning normally.

The chemical development of Olr1479 inhibitors involves a comprehensive approach to optimizing various properties, including the affinity of the inhibitors for the receptor, their selectivity to avoid off-target effects, and their chemical stability. Techniques such as molecular docking and computational modeling are often employed to visualize how potential inhibitors fit into the receptor's binding sites, providing insights that guide the design of more effective compounds. High-throughput screening is another critical tool used to identify promising candidates from large libraries of chemical compounds, which are then refined through structure-activity relationship (SAR) studies. These studies involve modifying the chemical structure of the inhibitors to improve their potency and selectivity, often by altering the core scaffold or functional groups to enhance interactions with the receptor. Additionally, researchers must consider physicochemical properties such as solubility, lipophilicity, and metabolic stability, which are essential for ensuring that the inhibitors can function effectively in various biological environments. The ongoing study and development of Olr1479 inhibitors contribute to a deeper understanding of olfactory signal transduction and the complex mechanisms by which GPCRs mediate cellular responses to external stimuli.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$79.00
$416.00
1
(1)

Beta-1 adrenergic receptor antagonist, may indirectly modulate GPCR signaling, potentially impacting Olr1479.

Candesartan

139481-59-7sc-217825
sc-217825B
sc-217825A
10 mg
100 mg
1 g
$47.00
$94.00
$151.00
6
(1)

Angiotensin II receptor blocker, can influence GPCR signaling indirectly, affecting Olr1479.

Clonidine

4205-90-7sc-501519
100 mg
$240.00
1
(0)

Alpha-2 adrenergic agonist, might alter GPCR signaling indirectly through adrenergic pathways, impacting Olr1479.

Eplerenone

107724-20-9sc-203943
sc-203943A
10 mg
50 mg
$110.00
$624.00
4
(1)

Mineralocorticoid receptor antagonist, could modulate GPCR signaling indirectly, impacting Olr1479.

Felodipine

72509-76-3sc-201483
sc-201483A
10 mg
50 mg
$91.00
$222.00
1
(1)

Calcium channel blocker, may affect GPCR signaling indirectly via calcium modulation, impacting Olr1479.

Nebivolol

99200-09-6sc-279910
100 mg
$803.00
1
(0)

Beta-1 adrenergic receptor antagonist, could alter GPCR signaling indirectly, impacting Olr1479.

Ramipril

87333-19-5sc-205833
sc-205833A
sc-205833B
sc-205833C
sc-205833D
500 mg
1 g
2 g
5 g
10 g
$179.00
$245.00
$364.00
$733.00
$1254.00
1
(1)

ACE inhibitor, may influence GPCR signaling indirectly via the renin-angiotensin system, impacting Olr1479.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$72.00
$94.00
8
(1)

Angiotensin II receptor blocker, can affect GPCR signaling indirectly, potentially impacting Olr1479.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$40.00
$92.00
$122.00
4
(1)

Angiotensin II receptor antagonist, might modulate GPCR signaling indirectly, impacting Olr1479.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blocker, could influence GPCR signaling indirectly through calcium ion dynamics, impacting Olr1479.